Is Hyplafin an effective and safe drug for BPH?

According to the recommendations presented in the medical literature, Hyplafin (finasteride) is one of the standard drugs used in the treatment of BPH. Clinical studies show a rapid decrease in the volume of the prostate gland. After 3 months, the volume of the prostate gland decreases by about 20% and this process progresses reaching about 27% after 3 years: https://www.gdziepolek.pl/produkty/36960/hyplafin-tabletki-powlekane/ulotka/123976 Benign Prostatic Hyperplasia (BPH), otherwise known as benign prostatic hyperplasia, is a non-cancerous enlargement of the prostate, that is, the small gland surrounding the male urethra, producing fluid that is part of the semen. The most common symptoms of BPH are: frequenturia, the need to urinate at night, narrowing of the urine stream, frequent rapid urge to urinate and prolongation of the micturition time. The main objectives of pharmacological treatment are: 1) elimination or alleviation of lower urinary tract ailments and improvement of the quality of life, 2) inhibition of BPH progression and counteracting the occurrence of its adverse consequences, such as: urinary tract infection, bladder urolithiasis, acute urinary retention, development of bladder diverticula, impairment of upper urinary tract function or avoidance of surgical intervention. I also encourage you to read the article: https://www.gdziepolek.pl/artykuly/jak-wyleczyc-chora-prostate